Compliance Certificate under Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018 for the quarter ended 30 September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited has submitted a routine compliance certificate to BSE for the quarter and half year ended 30 September 2025, as required under SEBI's Depositories and Participants Regulations. The certificate, issued by the company's Registrar and Share Transfer Agent (Adroit Corporate Services Pvt. Ltd.), confirms that all securities received from depository participants for dematerialisation during the period were properly processed, confirmed to the depositories, and listed on stock exchanges. The RTA also confirms that physical share certificates received for demat were mutilated and cancelled, and the depository's name was recorded as the registered owner within the mandated 15-day window. The filing was signed by Director Ghanshyam Dhananjay Gavali on 14 October 2025. This is a standard procedural submission, not a material business event.
This is a routine regulatory compliance filing with no material impact on the company's financials, operations, or share price. It simply confirms the orderly processing of dematerialisation requests during the quarter.